Chief Scientific Officer, Research, Parker Institute for Cancer Immunotherapy, Singapore

• Speaker, Oncology, and Cancer and Stem Cell Biology Symposium, 17 Sep 2021 

Assoc Prof John Connolly is the Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), where he designs and executes PICI’s overall research strategy in close collaboration with the institute’s leadership team, centre directors and scientific steering committee.
 
He is an Associate Professor at the National University of Singapore and an Adjunct Associate Professor of Immunology at the Baylor University, where he served on the Board of Governors for the Institute of Biomedical Sciences. He is also the Research Director and Director for Translational Immunology at Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR) and, the Director for the IMPACT Programme.